• MCC950 Sodium: Precision NLRP3 Inflammasome Inhibition Tool

  2026-06-03

  MCC950 sodium (CRID3 sodium salt) is a highly selective inhibitor of the NLRP3 inflammasome, widely applied in inflammatory disease research. The compound demonstrates nanomolar potency in both murine and human macrophages and shows efficacy in vivo for autoimmune disease models. Its specificity and solubility profile make it an essential tool for dissecting NLRP3-associated inflammation.

• Cyclic di-GMP: Protocols to Advance Biofilm and Immune Resea

  2026-06-03

  Cyclic di-GMP stands apart as an intracellular second messenger with dual-domain impact: it regulates bacterial biofilm stability and powers mammalian immune modulation through STING activation. This article bridges groundbreaking mechanistic insights with actionable workflows, offering researchers practical guidance for both infection biology and cancer immunotherapy studies.

• Brain-to-Spinal Circuits Govern Mechanical Allodynia in Mice

  2026-06-02

  Huo et al. (2023) delineate a brain-to-spinal circuit involving Oprm1-expressing neurons in the lateral parabrachial nucleus and Pdyn neurons in the dorsal medial hypothalamus that modulates the laterality and persistence of mechanical allodynia in mice. Their findings clarify descending neural mechanisms that gate bilateral pain hypersensitivity and offer new strategies for modeling chronic pain in translational neuroscience.

• HotStart™ 2X Green qPCR Master Mix: Mechanism, Evidence & Us

  2026-06-02

  HotStart™ 2X Green qPCR Master Mix enables highly specific, sensitive SYBR Green-based real-time PCR by leveraging antibody-mediated Taq polymerase inhibition. This master mix is optimized for gene expression analysis and nucleic acid quantification, offering reproducibility and a wide dynamic range.

• Bestatin (Ubenimex) in Cell Assays: Data-Driven Laboratory S

  2026-06-01

  Discover how Bestatin (Ubenimex), SKU A2575, empowers researchers to tackle real-world challenges in apoptosis, MDR, and aminopeptidase assays. This article provides scenario-based strategies and evidence-backed insights to maximize reproducibility and interpretability in cell viability workflows. Links to protocols and performance data ensure practical value for biomedical scientists.

• Bestatin (Ubenimex) in Cancer Pathways: Mechanisms & Researc

  2026-06-01

  Explore how Bestatin (Ubenimex) uniquely modulates aminopeptidase activity in cancer research. This article unveils advanced mechanistic insights, protocol guides, and expert analysis distinct from existing resources.

• Novel Antifungal Pipeline Strategies Against Candida auris R

  2026-05-31

  A recent systematic review evaluates emerging antifungal drugs targeting multidrug-resistant Candida auris, highlighting new mechanisms and improved in vivo efficacy. The paper underscores the urgent need for innovative agents, such as selective tetrazoles, to address resistance and therapeutic limitations.

• EZ Cap EGFP mRNA 5-moUTP: Optimized Workflows and Applicatio

  2026-05-30

  EZ Cap™ EGFP mRNA (5-moUTP) unlocks robust, immune-evasive protein expression for advanced gene regulation, imaging, and mRNA delivery assays. This guide details experimental workflows, troubleshooting, and actionable insights from recent machine learning-driven delivery breakthroughs.

• DeferoxamineB: Protocol Innovations in Cancer Research Assay

  2026-05-29

  Deferoxamine (DeferoxamineB) is more than a conventional iron chelator—its ability to modulate ferroptosis, cuproptosis, and antitumor immunity enables advanced metabolic intervention strategies in cancer models. This article translates breakthrough findings and real-world troubleshooting into actionable protocols, ensuring researchers extract maximal value from DeferoxamineB in regulated cell death and immunometabolic studies.

• Nystatin (Fungicidin): Unraveling Advanced Antifungal Mechan

  2026-05-29

  Explore the advanced molecular actions of Nystatin (Fungicidin) against Candida and Aspergillus species, with a focus on resistance, cell adhesion, and translational boundaries. This article delivers a unique, research-driven perspective rooted in mechanistic insights and evidence-based assay strategy.

• Quinolone–Coumarin Hybrids and Novobiocin Against Toxoplasma

  2026-05-28

  This study introduces quinolone–coumarin hybrids derived from fluoroquinolones and the aminocoumarin antibiotic Novobiocin as potent antiparasitic agents against Toxoplasma gondii. The findings highlight specific hybrids and Novobiocin itself as promising candidates for safer, selective anti-Toxoplasma therapy, underscoring their potential for further translational research.

• DeferoxamineB: Mechanistic Precision in Iron Modulation for

  2026-05-28

  Discover how Deferoxamine (DeferoxamineB) from APExBIO uniquely enables mechanistic iron modulation in cancer research. This in-depth article explores its biochemical actions, advanced protocol strategies, and how it advances beyond existing metabolic intervention studies.

• VX-661 and Variant-Specific CFTR Rescue: From Calnexin Insig

  2026-05-27

  Explore how VX-661, a F508del CFTR corrector, enables precision modulation of CFTR variants in cystic fibrosis research. This article uniquely unpacks calnexin’s role and advanced assay strategies for next-generation study designs.

• Lactoferrin Potentiates Novobiocin Activity Against E. coli

  2026-05-27

  This study demonstrates that bovine lactoferrin significantly enhances the bactericidal activity of Novobiocin, an aminocoumarin antibiotic, against both laboratory and mastitis-associated strains of Escherichia coli. The findings suggest that combining immune components such as lactoferrin with antibiotics may help overcome intrinsic resistance in Gram-negative pathogens and inform future approaches to antibacterial resistance research.

• Bestatin (Ubenimex): Precision Aminopeptidase Inhibition in

  2026-05-26

  Bestatin (Ubenimex) is a gold-standard aminopeptidase inhibitor, transforming multidrug resistance (MDR) research and apoptosis assay workflows with unmatched selectivity and nanomolar potency. Discover protocol-driven troubleshooting strategies and innovative applications that put APExBIO’s Bestatin at the core of next-generation cancer and antimalarial studies.

11881 records 6/793 page Previous Next First page 上5页 678910 下5页 Last page